NCT05835466
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05835466
Title Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Icahn School of Medicine at Mount Sinai
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Moffitt Cancer Center RECRUITING Tampa Florida 33612 United States Details
Emory University NOT_YET_RECRUITING Atlanta Georgia 30322 United States Details
Roswell Park Cancer Institute RECRUITING Buffalo New York 14263 United States Details
Ruttenberg Treatment Center RECRUITING New York New York 10029 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
NewYork-Presbyterian/Weill Cornell Medical Center RECRUITING New York New York 10065 United States Details
Wake Forest Baptist Health Comprehensive Cancer Center RECRUITING Winston-Salem North Carolina 27157 United States Details
The Cleveland Clinic Foundation NOT_YET_RECRUITING Cleveland Ohio 44195 United States Details
The Ohio State University NOT_YET_RECRUITING Columbus Ohio 43210 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field